GamaMabs Pharma develops monoclonal antibodies for the treatment of cancer.
Business Model:
Revenue: $9.3M
Employees: 11-50
Address: 1 place Pierre Potier
City:
State: other
Zip: 50624
Country: FR
GamaMabs Pharma develops monoclonal antibodies for the treatment of cancer.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2013 | Series A | 1 | $4.2M |
Bpifrance Bpifrance |
12/2015 | Series B | $15.9M |
Alto Invest IXO Private Equity Irdinov Edmond de Rothschild Investment Partners Bpifrance |
12/2015 | Series B | 5 | $16.4M |
IXO Private Equity IRDInov InnoBio Andera Partners Alto Invest IXO Private Equity IRDInov InnoBio Andera Partners Alto Invest |
12/2015 | Series B | 5 | $16.4M |
Alto Invest Andera Partners InnoBio IRDInov IXO Private Equity Alto Invest Andera Partners InnoBio IRDInov IXO Private Equity |
9/2013 | Series A | 1 | $4.2M |
Bpifrance Bpifrance |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|